Lee Schwartzberg, Md, Explains Technology Assistance As The Chief Medical Officer For Oneoncology

Lee Schwartzberg, MD, explains technology assistance as the Chief Medical Officer for OneOncology

Lee Schwartzberg, MD, explains the key drivers of success for OneOncology

Lee Schwartzberg MD, shares exciting initiatives in the works in his role at OneOncology

Lee Schwartzberg, MD, shares his goals as medical director of OneOncology

Dr Lee Schwartzberg Reflects on the First Year of OneOncology

Jeff Vacirca, MD, explains why OneOncology is a unique practice model

Dr Lee Schwartzberg: How OneOncology Will Help Community Practices Navigate Cancer Care Landscape

Lee Schwartzberg, MD, describes how OneOncology is blazing a trial in clinical trial accrual

Lee Schwartzberg, MD, on whether clinical trial experience with I-O translates to routine care

Lee Schwartzberg, MD, on how step therapy & utilization management are impacting community oncology

Dr Jeff Patton: How OneOncology Will Support Patients Throughout the Continuum of Care

Dr Lee Schwartzberg Outlines Potential Steps to Expand Access of Novel Therapies in Immuno-Oncology

Lee Schwartzberg, MD - Hematology Oncology

Dr Lee Schwartzberg Explains the Promise of Liquid Biopsies in Cancer

Lee Schwartzberg, MD, on OneOncology embracing CAR-T and policies to prevent financial toxicity

Dr Lee Schwartzberg Reflects on the Approval of the First Immunotherapy Regimen in Breast Cancer

Dinesh Kapur, MD, explains why his practice eventually decided to join OneOncology

Dr. Schwartzberg on the Use of Therapeutic Biosimilars in Breast Cancer

Introduction to Integrative Oncology at Tennessee Oncology/OneOncology

ACCC Immuno-Oncology Institute resources help navigate complexities of immunotherapies